Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...
BioLineRx & Hemispherian announce new preclinical data demonstrating strong synergistic effect between GLIX1 and PARP inhibitor in a patient-derived ovarian cancer xenograft model ...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology ...
Scientists have finally uncovered how bacteria naturally create multiple versions of powerful anti-cancer drugs, solving a mystery that has frustrated researchers for decades.
A new evolutionary theory suggests that some asexual parasites may temporarily be able to infect a wider range of hosts as harmful genetic mutations build up. In a paper published in Trends in ...
The researchers’ CIGS-perovskite tandem solar cell achieved a conversion efficiency of 25.5%, a record for this material combination. Image: G. Farias Basulto/HZB German researchers have achieved a ...
Leading AI labs, executives, and scientists are sending a letter to lawmakers urging them to improve tracking of synthetic DNA sequences that could be used for bioweapons. The CEOs of several major ...
Deutsche Telekom AG is discussing a potential combination with its American arm T-Mobile US Inc., people familiar with the matter said, a move that would create the world’s biggest phone company and ...
Despite long-standing interest in combining topoisomerase I (TOP1) poisons with PARP inhibitors (PARPis), the mechanistic basis for the variable and often unpredictable response to this strategy ...
Search for other works by this author on: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results